Cite
APA Citation
Ohara, S., Suda, K., Fujino, T., Hamada, A., Koga, T., Nishino, M., Chiba, M., Shimoji, M., Takemoto, T., Soh, J., & Mitsudomi, T. (2021). dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer. Lung cancer, 154, 84–91. http://access.bl.uk/ark:/81055/vdc_100124369039.0x000040